Table 3.
Tracers | Number of prostheses | Sensitivity (%) | Specificity (%) | |
---|---|---|---|---|
Simonsen et al. [13] | LLS | 76 | 81 | 94 |
Teller et al. [14] | LLS | 166 | 64 | 78 |
Larikka et al. [15] | LLS | 30 | 62 | 100 |
Pelosi et al. [16] | LLS | 95 | 85 | 71 |
Trevail et al. [17] | LLS | 221 | 80 | 99.5 |
Erba et al. [18] | LLS | 132 | 93 | 100 |
Gratz et al. [19] | AGS | 20 | 100 | 83 |
Sousa et al. [20] | AGS | 27 | 100 | 20 |
Rubello et al.(21) | AGS | 78 | 93 | 78 |
Pakos et al.(22) | AGS | 19 | 75 | 86 |
LLS in vitro labelled leucocyte scintigraphy, AGS anti-granulocyte scintigraphy